Development code · Biologic

ION363

ION363 is a development code for Ulefnersen (ION363), developed by Ionis Pharmaceuticals, Inc..

Status: Phase 3 for Amyotrophic lateral sclerosis
Mechanism: FUS Inhibitor
Developer: Ionis Pharmaceuticals, Inc.

Programs

Ulefnersen (ION363) for Amyotrophic lateral sclerosisPhase 3Active

Also known as

ION-363
Jacifusen
Ulefnersen
2589926-25-3

View the full Ulefnersen (ION363) profile →